Imagine if your diet and exercise plan were designed like a custom-tailored suit, fitting your specific DNA and gut bacteria. Instead of one-size-fits-all advice, this system uses AI to figure out why some people struggle more with weight than others. It then gives personalized tips that actually work for your specific body and lifestyle.
Current obesity interventions are generic and often fail because they ignore the biological and genetic differences between individuals. This leads to wasted healthcare spending and poor patient outcomes.
A unified research database of genetic and metabolic data and a causal AI model for personalized weight prevention. They also developed real-time behavioral monitoring tools.
If you are a health-tech app developer dealing with high user churn due to generic diet plans — this project developed a causal AI model and real-time monitoring tools that provide personalized lifestyle guidance. This allows for higher user success rates based on genetic and metabolic data.
If you are a health insurance provider dealing with rising obesity-related claims — this project developed evidence-based prevention guidelines and a methodology to identify weight gain determinants. This helps in creating more effective preventative care programs for policyholders.
If you are a personalized nutrition company dealing with a lack of clinical evidence for your product claims — this project analyzed data from over 1 million individuals to link metabolomic signatures to BMI. This provides a scientific basis for targeting specific biochemical subgroups with tailored products.
Based on available project data, there is no specific pricing or cost structure mentioned for the end-user or commercial implementation.
The project aims to develop scalable, AI-driven strategies and evaluates implementation feasibility across different settings to ensure the methodology can be widely applied.
Based on available project data, specific IP or licensing agreements are not detailed, though the project involves 30 partners including 2 SMEs and 2 industry entities.
The project has already achieved database integration and data harmonization across cohorts, combining genetic, metabolic, and behavioral data into a unified research database.
The project period runs from 2023-11-01 to 2027-10-31, with the final dissemination of sustainable prevention guidelines occurring toward the end of this period.
The consortium is heavily academic, with 18 universities and 2 research institutes leading the science. However, the inclusion of 2 industry partners and 2 SMEs, spanning 21 countries, suggests a strong intent to move the research toward commercial application and regional scalability across Europe.
Contact CHAROKOPEIO PANEPISTIMIO in Greece for partnership inquiries.
Contact us to explore licensing opportunities for the causal AI obesity models.
